France's import of insulin in dosage forms is projected to experience steady growth from 2024 to 2028. In 2023, imports were at 3.4295 million kilograms. Starting in 2024, a positive trajectory is forecasted, with consistent year-on-year increases. Comparing 2024 to 2025, there's an increase of 3.58%, and from 2025 to 2026, a further rise of 3.39%. The pattern continues with a 3.21% increase in 2027 and a 3.05% increase in 2028. The compounded annual growth rate (CAGR) over this five-year period is estimated at 3.23%.

Future trends to watch for:

Regulatory changes in the pharmaceutical sector, potentially impacting import dynamics.
Advancements in insulin technologies that may influence demand for specific dosage forms.
Market conditions affecting the global supply chain and pricing structures.
Shifts in healthcare policies and diabetic patient demographics in France.